Blog
Featured post
Truveta supports regulatory submissions to the FDA and global regulatory authorities
With industry-leading certifications and rigorous third-party audits, Truveta announces new capabilities to enable successful regulatory submissions and audits.
Truveta and the University of Washington’s CHOICE Institute partner to advance health economics and outcomes research
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has partnered with Truveta to use its electronic...
Ensuring privacy and compliance of AI
Continuing with my series on AI, today I want to discuss the following question: How to make healthcare data available for clinical and life science research while leveraging AI...
ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs
Authors: Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc,...
ISPE 2024: Real-world patterns in GLP-1 RA switching from 2018-2023 in the US
Authors: Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl, PhD ⊕Truveta, Inc, Bellevue,...
Truveta moves up on GeekWire’s Top 200 startup list
Truveta was included in GeekWire’s latest list recognizing the top 200 startups in the Pacific Northwest. With this update of the GeekWire 200, Truveta moved up 14 spots to #38...
Advancing psoriasis research with regulatory-grade EHR data
Psoriasis is more than just a skin condition – it’s a chronic, systemic disease that affects over 8 million people in the United States, profoundly impacting their quality of...
Exploring medication switching trends from Humira to approved biosimilars
Authors: Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA,...
Improving ovarian cancer outcomes with EHR data
By the time most women with ovarian cancer are diagnosed, 70-80% are already at an advanced stage of the disease. Despite declining mortality rates over the past decade, the...
Scaling AI models for growth
In this blog I will discuss our approach to scaling our AI technologies across multiple dimensions while controlling development costs, operational costs, and assuring stability....